BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20583249)

  • 1. New technique using combined pulsed dye laser and fractional resurfacing for treating facial angiofibromas in tuberous sclerosis.
    Weiss ET; Geronemus RG
    Lasers Surg Med; 2010 Jul; 42(5):357-60. PubMed ID: 20583249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted topical and combination laser surgery for the treatment of angiofibromas.
    Bae-Harboe YS; Geronemus RG
    Lasers Surg Med; 2013 Nov; 45(9):555-7. PubMed ID: 24136238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of nodular facial angiofibromas in tuberous sclerosis, using ultrapulse carbon dioxide laser.
    Biondo G; Greco S; Mavilia L; Mercuri SR
    Clin Exp Dermatol; 2014 Aug; 39(6):738-40. PubMed ID: 24890518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co2/Erbium:YAG/Dye laser combination: an effective and successful treatment for angiofibromas in tuberous sclerosis.
    Fioramonti P; De Santo L; Ruggieri M; Carella S; Federico LT; Onesti MG; Scuderi N
    Aesthetic Plast Surg; 2014 Feb; 38(1):192-198. PubMed ID: 24337149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of angiofibromas of tuberous sclerosis with 5-aminolevulinic acid blue light photodynamic therapy followed by immediate pulsed dye laser.
    Weinberger CH; Endrizzi B; Hook KP; Lee PK
    Dermatol Surg; 2009 Nov; 35(11):1849-51. PubMed ID: 19682000
    [No Abstract]   [Full Text] [Related]  

  • 6. Unilateral facial angiofibromas--a segmental form of tuberous sclerosis.
    McGrae JD; Hashimoto K
    Br J Dermatol; 1996 Apr; 134(4):727-30. PubMed ID: 8733380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Angiofibromas in a Tuberous Sclerosis Patient Using Topical Timolol 0.5% Gel.
    Krakowski AC; Nguyen TA
    Pediatrics; 2015 Sep; 136(3):e709-13. PubMed ID: 26304829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unilateral multiple facial angiofibromas: a mosaic form of tuberous sclerosis.
    Silvestre JF; Bañuls J; Ramón R; Guijarro J; Botella R; Betlloch I
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):127-9. PubMed ID: 10863238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of facial angiofibroma of tuberous sclerosis using cultured epithelial autografts.
    Hori K; Soejima K; Nozaki M; Sakurai H; Takeuchi M; Yamaki T; Iwasaka S; Kono T; Honda T; Isago T
    Ann Plast Surg; 2006 Oct; 57(4):415-7. PubMed ID: 16998334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Hot" KTP-laser treatment of facial angiofibromata.
    Tope WD; Kageyama N
    Lasers Surg Med; 2001; 29(1):78-81. PubMed ID: 11500867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral facial angiofibromas; a review of the literature.
    Camprubí M; Balaguer A; Azon Masoliver A; Jiménez-Feijoo R; Escribano Subias J
    Pediatr Dermatol; 2006; 23(3):303-5. PubMed ID: 16780491
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral manifestations leading to the diagnosis of familial tuberous sclerosis.
    Martelli H; Lima LS; Bonan PR; Coletta RD
    Indian J Dent Res; 2010; 21(1):138-40. PubMed ID: 20427926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resurfacing of facial angiofibromas in tuberous sclerosis patients using CO2 laser with flashscanner.
    Song MG; Park KB; Lee ES
    Dermatol Surg; 1999 Dec; 25(12):970-3. PubMed ID: 10594634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nd:YAG laser for "fractional" treatment of angiofibromas.
    Ma G; Wu P; Lin X; Chen H; Li W; Hu X; Jin Y
    Int J Dermatol; 2014 May; 53(5):638-42. PubMed ID: 24602020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis complex.
    Balestri R; Neri I; Patrizi A; Angileri L; Ricci L; Magnano M
    J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):14-20. PubMed ID: 25174683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial angiofibromas treated by rapamycin 0.05% ointment and a combined laser therapy.
    Negosanti F; Tengattini V; Gurioli C; Neri I
    J Cosmet Dermatol; 2018 Oct; 17(5):762-765. PubMed ID: 30123982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of angiofibromas with a scanning carbon dioxide laser: a clinicopathologic study with long-term follow-up.
    Bittencourt RC; Huilgol SC; Seed PT; Calonje E; Markey AC; Barlow RJ
    J Am Acad Dermatol; 2001 Nov; 45(5):731-5. PubMed ID: 11606924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genital angiofibromas in tuberous sclerosis: two cases.
    Nico MM; Ito LM; Valente NY
    J Dermatol; 1999 Feb; 26(2):111-4. PubMed ID: 10091481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CO2, argon, and pulsed dye laser treatment of angiofibromas.
    Boixeda P; Sánchez-Miralles E; Azaña JM; Arrazola JM; Moreno R; Ledo A
    J Dermatol Surg Oncol; 1994 Dec; 20(12):808-12. PubMed ID: 7798412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical everolimus for facial angiofibromas in the tuberous sclerosis complex. A first case report.
    Dill PE; De Bernardis G; Weber P; Lösch U
    Pediatr Neurol; 2014 Jul; 51(1):109-13. PubMed ID: 24810875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.